874 results on '"Harada, Tasuku"'
Search Results
2. Outcome of robot-assisted surgery for stage IA endometrial cancer compared to open and laparoscopic surgeries: a retrospective study at a single institution
3. Efficacy and safety of a novel pain management device, AT-04, for endometriosis-related pain: study protocol for a phase III randomized controlled trial
4. Characterization of immortalized ovarian epithelial cells with BRCA1/2 mutation
5. Efficacy and safety of the combination of estetrol 15 mg/drospirenone 3 mg in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: a multicenter, placebo-controlled, double-blind, randomized study
6. First report of robotic-assisted total hysterectomy using the Hugo™ RAS system
7. A Call for New Theories on the Pathogenesis and Pathophysiology of Endometriosis
8. Role of tenascin C in lesion formation in early peritoneal endometriosis
9. Impact of adenomyosis on perinatal outcomes: a large cohort study (JSOG database)
10. Efficacy and safety of estetrol (15 mg)/drospirenone (3 mg) combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: a multicenter, placebo-controlled, double-blind, randomized study
11. P2X4 receptor mediates macrophage infiltration leading to endometriotic cyst epithelium proliferation and hyperalgesia in mouse model
12. Increased chemokine ligand 26 expression and its involvement in epithelial-mesenchymal transition in the endometrium with adenomyosis
13. Hormonal Therapy in Endometriosis and Adenomyosis: Oral Contraceptives
14. Quality of Life of Japanese Dysmenorrhea/Heavy Menstrual Bleeding Patients Treated with Levonorgestrel Intrauterine Delivery System in a Real-World Setting
15. Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI)
16. SR‐16234, a Unique Selective Estrogen Receptor Modulator, Suppressed Proliferation and Pain‐Related Factor Expression by Inhibition of the Nuclear Factor‐kappa B Pathway in Endometriotic Stromal Cells.
17. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study
18. Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
19. D-dimer level significance for deep vein thrombosis screening in the third trimester: a retrospective study
20. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system
21. List of contributors
22. Novel therapeutic strategy: antiinflammatory reagents
23. Ultralong administration of gonadotropin-releasing hormone agonists before in vitro fertilization improves fertilization rate but not clinical pregnancy rate in women with mild endometriosis: a prospective, randomized, controlled trial
24. Comparison of Surgical Outcomes of da Vinci Surgical Systems X and Xi: A Single-center Study
25. Corrigendum to “Increased chemokine ligand 26 expression and its involvement in epithelial-mesenchymal transition in the endometrium with adenomyosis” [Volume 52, Issue 9 (2023) 102645]
26. A National Survey of Umbilical Endometriosis in Japan
27. lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer
28. First Report of Hybrid Laparoscopic Hysterectomy Using the Hugo™ RAS System
29. Comparison of surgical outcomes of da Vinci surgical systems X and Xi: A single‐center study.
30. New surgery technique combining robotics and laparoscopy using the Hugo™ RAS system.
31. Comparison of laparoscopic surgery and conventional laparotomy for surgical staging of patients with presumed low-risk endometrial cancer: The current state of Japan
32. Outcome of robot-assisted surgery for stage IA endometrial cancer compared to open and laparoscopic surgery: A retrospective study at a single institution
33. First report of robotic-assisted total hysterectomy using the Hugo™ RAS system
34. Evaluation of the characteristics of ovarian endometrioma in patients with endometriosis: efficacy of a low-dose estrogen/progestogen combination
35. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer
36. Authors’ Reply
37. Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial
38. Deep vein thrombosis and serum D-dimer after pelvic lymphadenectomy in gynecological cancer
39. Surgical Management of Endometriosis
40. Epigenetics in Endometriosis
41. Inflammation and Cytokines in Endometriosis
42. Endometriosis in Experimental Models
43. Endometriosis: A Mysterious Disease
44. Apoptosis in Endometriosis
45. The learning curve of introduced robotic‐assisted hysterectomy versus skilled laparoscopic hysterectomy for benign gynecologic diseases
46. Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo-controlled, double-blind, randomized trial
47. Impact of Estetrol Combined with Drospirenone on Blood Coagulation and Fibrinolysis in Patients with Endometriosis: A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel-Group Study.
48. Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma
49. Is Adjuvant Chemotherapy Necessary in Patients with Early Endometrial Cancer?
50. The spectrum of imaging appearances of müllerian duct anomalies: focus on MR imaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.